Page last updated: 2024-08-25

3-deazaneplanocin and Neoplasms, Pleural

3-deazaneplanocin has been researched along with Neoplasms, Pleural in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bueno, R; De Rienzo, A; Fetsch, P; Filie, A; Hong, JA; Inchauste, S; Kemp, CD; Liu, F; Mani, H; Marquez, VE; Mathur, A; Meltzer, PA; Rao, M; Ripley, RT; Schrump, DS; Walker, RL; Xi, S; Yang, M; Zhang, M; Zhu, YJ1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Neoplasms, Pleural

ArticleYear
Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jan-01, Volume: 18, Issue:1

    Topics: Adenosine; Adult; Aged; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Chromatin Immunoprecipitation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Mesothelioma; Mice; Mice, Nude; MicroRNAs; Oligonucleotide Array Sequence Analysis; Pleural Neoplasms; Polycomb Repressive Complex 2; Polycomb-Group Proteins; Real-Time Polymerase Chain Reaction; Repressor Proteins; RNA, Messenger; RNA, Small Interfering; Transcription Factors

2012